254 related articles for article (PubMed ID: 30031488)
1. Update on Topical Treatments for Psoriasis: The Role of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam.
Puig L; Carretero G
Actas Dermosifiliogr (Engl Ed); 2019 Mar; 110(2):115-123. PubMed ID: 30031488
[TBL] [Abstract][Full Text] [Related]
2. Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.
Kim ES; Frampton JE
Drugs; 2016 Oct; 76(15):1485-1492. PubMed ID: 27663245
[TBL] [Abstract][Full Text] [Related]
3. Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile.
Paul C; Bang B; Lebwohl M
Expert Opin Pharmacother; 2017 Jan; 18(1):115-121. PubMed ID: 27936972
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation.
Gallo L; Megna M; Cirillo T; Caterino P; Lodi G; Mozzillo R; Dente V; Balato A
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1312-1315. PubMed ID: 30767288
[TBL] [Abstract][Full Text] [Related]
5. Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study.
Griffiths CE; Stein Gold L; Cambazard F; Kalb RE; Lowson D; Møller A; Paul C
Eur J Dermatol; 2018 Jun; 28(3):356-363. PubMed ID: 29952297
[TBL] [Abstract][Full Text] [Related]
6. Changes in interleukin-17A, macrophage-derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO-ABLE study.
Røpke M; Bulai Livideanu C; Kaldate R; Snel A; Paul C
Br J Dermatol; 2018 Jan; 178(1):e33-e34. PubMed ID: 28722136
[No Abstract] [Full Text] [Related]
7. Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review.
Yan R; Jiang S; Wu Y; Gao XH; Chen HD
Indian J Dermatol Venereol Leprol; 2016; 82(2):135-44. PubMed ID: 26924402
[TBL] [Abstract][Full Text] [Related]
8. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
Fenton C; Plosker GL
Am J Clin Dermatol; 2004; 5(6):463-78. PubMed ID: 15663344
[TBL] [Abstract][Full Text] [Related]
9. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
McCormack PL
Drugs; 2011 Apr; 71(6):709-30. PubMed ID: 21504248
[TBL] [Abstract][Full Text] [Related]
10. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
Douglas WS; Poulin Y; Decroix J; Ortonne JP; Mrowietz U; Gulliver W; Krogstad AL; Larsen FG; Iglesias L; Buckley C; Bibby AJ
Acta Derm Venereol; 2002; 82(2):131-5. PubMed ID: 12125943
[TBL] [Abstract][Full Text] [Related]
11. Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching-adjusted indirect comparison.
Bewley AP; Shear NH; Calzavara-Pinton PG; Hansen JB; Nyeland ME; Signorovitch J
J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1107-1115. PubMed ID: 30472749
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel.
Tan ES; Oon HH
Indian J Dermatol Venereol Leprol; 2016; 82(3):345-7. PubMed ID: 27088952
[No Abstract] [Full Text] [Related]
13. Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
Girolomoni G; Vena GA; Ayala F; Cannavò SP; De Pità O; Chimenti S; Peserico A
G Ital Dermatol Venereol; 2012 Dec; 147(6):609-24. PubMed ID: 23149707
[TBL] [Abstract][Full Text] [Related]
14. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
Claréus BW; Houwing R; Sindrup JH; Wigchert S
Eur J Dermatol; 2009; 19(6):581-5. PubMed ID: 19726275
[TBL] [Abstract][Full Text] [Related]
15. Calcipotriene plus betamethasone dipropionate in aerosol foam formulation: will this effective treatment for mild-to-moderate psoriasis change clinical practice?
Giovene GL; Giacomelli L;
G Ital Dermatol Venereol; 2018 Dec; 153(6):872-876. PubMed ID: 30261718
[TBL] [Abstract][Full Text] [Related]
16. A Cost-utility Analysis of Calcipotriol/Betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden.
Duvetorp A; Levin LÅ; Engerstedt Mattsson E; Ryttig L
Acta Derm Venereol; 2019 Apr; 99(4):393-399. PubMed ID: 30628631
[TBL] [Abstract][Full Text] [Related]
17. Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.
Paul C; Leonardi C; Menter A; Reich K; Gold LS; Warren RB; Møller A; Lebwohl M
Am J Clin Dermatol; 2017 Jun; 18(3):405-411. PubMed ID: 28236223
[TBL] [Abstract][Full Text] [Related]
18. Back to the future: a new topical approach for mild-to-moderate psoriasis.
Girolomoni G; Calzavara Pinton P; Cristaudo A; Cicchetti A
G Ital Dermatol Venereol; 2018 Jun; 153(3):375-382. PubMed ID: 27982547
[TBL] [Abstract][Full Text] [Related]
19. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.
Koo J; Tyring S; Werschler WP; Bruce S; Olesen M; Villumsen J; Bagel J
J Dermatolog Treat; 2016; 27(2):120-7. PubMed ID: 26444907
[TBL] [Abstract][Full Text] [Related]
20. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
